Shingles Cases Rise Among Under-50s in Spain

Shingles in Under-50s: The Unexplained Surge

Shingles has ceased to be an elderly-only disease. Increasingly, people under 50 suffer outbreaks of a bicho that remains latent since chickenpox, and the question—what is happening?—is being asked aloud in clinics, pharmacies, and public discourse. The honest answer: there is no confirmed cause. Four competing theories exist, alongside a growing healthcare business mirroring the alarm. It is essential to separate known facts from suspicions.

Why so many shingles cases in under-50s?

According to the most repeated hypotheses, more people have compromised cellular immunity. The varicella-zoster bicho never leaves the body; it sleeps in nerve ganglia and reactivates during any drop in defenses, causing painful rashes. Shingles arises from lowered defenses, there you go, summarizes one message. The doubt is what causes this drop in people under 50. Explanations cluster into four blocks: the ELbichito vaccine, the chickenpox vaccine, stress combined with vitamin D deficiency, and ELbichito itself destabilizing the immune system. None are proven.

The ELbichito vaccine: the most repeated suspicion, least tested

Eduardo López Bran, dermatology professor at Complutense University of Madrid, addressed this in The Conversation: mass vaccination campaigns have occasionally caused skin reactions that may generate concern, such as shingles. Many messages leap directly to blaming injections, claiming it is a recognized adverse effect that devastates defenses. No evidence supports this causal link, and no health authority has established it. This hypothesis has the most echo but accumulates the fewest proofs.

Chickenpox, the vaccine, and immune training

A second line points to the chickenpox vaccine, incorporated into schedules relatively late. The reasoning is that contracting the disease as a child provides training the vaccine does not replicate equally, leaving the bicho latent in those who never had it or had it as adults, when outbreaks are more severe. Counterarguments rely on common sense: the vaccine prevents serious complications, and its widespread use globally has not triggered a corresponding shingles surge. Those with shingles can transmit chickenpox to those who haven't had it, though cold sores are distinct and often confused.

Stress, sleep deprivation, and low vitamin D

Here, consensus is broader. Chronic stress, poor sleep, persistent inflammation, and low vitamin D levels—considered low below 25—create fertile ground for viral reactivation. One person shares their experience: suffering outbreaks since birth, including dangerous eye involvement, triggered by high-stress periods or depressed immunity. Another describes a thigh episode after weeks of long standing shifts, having never received a ELbichito dose and having had chickenpox as a child. The pattern repeats: the trigger is not the bicho, but the body's state.

The business: €33.7 million in Madrid and soaring antiviral sales

The Community of Madrid approved €33.7 million for shingles vaccination, plastering public health centers with campaign materials. Meanwhile, claims suggest Acyclovir sales rose 500%, with a supplier exporting from Belarus. The offered vaccine is presented as using the same technology as ELbichito shots. Beware the fine print: those who have already had shingles are not exempt, as the bicho remains lifelong. Affected individuals warn that some doctors still confuse the rash with other ailments, treating anything but the nerve pain.

What remains unresolved

With vaccination expanding among older adults and antiviral sales multiplying, the issue will likely gain volume—and noise—before anyone can explain with data why shingles is striking younger people. If an explanation emerges, it will come via epidemiology, with series separating vaccine effects from infection impacts. If not, the easiest path prevails: blaming the jab.